Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats.

Melo-Carrillo A, Strassman AM, Schain AJ, Noseda R, Ashina S, Adams A, Brin MF, Burstein R.

Cephalalgia. 2019 Oct;39(11):1358-1365. doi: 10.1177/0333102419873675. Epub 2019 Aug 31.


CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP's Role in Migraine with Aura.

Schain AJ, Melo-Carrillo A, Stratton J, Strassman AM, Burstein R.

J Neurosci. 2019 Jul 24;39(30):6001-6011. doi: 10.1523/JNEUROSCI.0232-19.2019. Epub 2019 May 24.


Reducing Risks for Older Adults With an Interprofessional Community-Academic Partnership: A Case Study.

Schain A, Rees C, Medina C, Eyler R, Glenney S, Rodko E, Cassese J, Shellman J, Malcolm M.

Home Healthc Now. 2018 Nov/Dec;36(6):362-368. doi: 10.1097/NHH.0000000000000696.


Activation of pial and dural macrophages and dendritic cells by cortical spreading depression.

Schain AJ, Melo-Carrillo A, Borsook D, Grutzendler J, Strassman AM, Burstein R.

Ann Neurol. 2018 Mar;83(3):508-521. doi: 10.1002/ana.25169. Epub 2018 Mar 13.


Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors.

Melo-Carrillo A, Strassman AM, Nir RR, Schain AJ, Noseda R, Stratton J, Burstein R.

J Neurosci. 2017 Nov 1;37(44):10587-10596. doi: 10.1523/JNEUROSCI.2211-17.2017. Epub 2017 Sep 29.


Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.

Melo-Carrillo A, Noseda R, Nir RR, Schain AJ, Stratton J, Strassman AM, Burstein R.

J Neurosci. 2017 Jul 26;37(30):7149-7163. doi: 10.1523/JNEUROSCI.0576-17.2017. Epub 2017 Jun 22. Erratum in: J Neurosci. 2017 Nov 8;37(45):11067.


Extracranial origin of headache.

Burstein R, Blake P, Schain A, Perry C.

Curr Opin Neurol. 2017 Jun;30(3):263-271. doi: 10.1097/WCO.0000000000000437. Review.


Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache.

Schain AJ, Melo-Carrillo A, Strassman AM, Burstein R.

J Neurosci. 2017 Mar 15;37(11):2904-2915. doi: 10.1523/JNEUROSCI.3390-16.2017. Epub 2017 Feb 13.


Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache.

Perry CJ, Blake P, Buettner C, Papavassiliou E, Schain AJ, Bhasin MK, Burstein R.

Ann Neurol. 2016 Jun;79(6):1000-13. doi: 10.1002/ana.24665. Epub 2016 May 5.


Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial.

Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, Mittleman MA, Burstein R.

Ann Neurol. 2015 Dec;78(6):970-81. doi: 10.1002/ana.24534. Epub 2015 Nov 13.


Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques.

Condello C, Yuan P, Schain A, Grutzendler J.

Nat Commun. 2015 Jan 29;6:6176. doi: 10.1038/ncomms7176.


Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy.

Schain AJ, Hill RA, Grutzendler J.

Nat Med. 2014 Apr;20(4):443-9. doi: 10.1038/nm.3495. Epub 2014 Mar 30.


Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition.

Condello C, Schain A, Grutzendler J.

Sci Rep. 2011;1:19. doi: 10.1038/srep00019. Epub 2011 Jun 21.


CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.

Liu Z, Condello C, Schain A, Harb R, Grutzendler J.

J Neurosci. 2010 Dec 15;30(50):17091-101. doi: 10.1523/JNEUROSCI.4403-10.2010.

Supplemental Content

Loading ...
Support Center